Russian President Vladimir Putin just announced the world’s first registration of a vaccine for the novel coronavirus, becoming the first nation in the world to do so.
Per the registration certificate, the vaccine is set to go in civilian circulation by January 2021. Russia’s prototype is a twin-dose jab which is expected to drive strong immune response to the SARS-CoVI-2 virus.
Putin, in his bombshell statement on Tuesday also revealed that one of his daughters has already been jabbed with the vaccine developed by Gamaleya Research Institute, which has shown promise in human trials, according to media reports.
Clinical trials of the vaccine were carried in June with 38 human volunteers, and all of them reportedly developed an immunity.
The president also claimed that the vaccine successfully induces a long-term immune response against the novel coronavirus that has so far infected over 20 million people globally.
More than 100 candidates have been rushing to launch the first vaccine, with Russia for some time recently leading the game. With the official registration of the vaccine, Russia dwarfed the world in the race for a COVID vaccine.
“I hope we will be able to start mass production of this medication in the near future, which is very important”, the president said, state media Sputnik quoted the Russain president.
“I hope that our colleagues abroad will also move forward, and there will be quite a lot of products that can be used on the market, on the world market for medicines and vaccines”, Putin added.
Putin also told teachers, medical and frontline workers will be the first to be inoculated with the vaccine, given their risky jobs amid masses.
Giving a description of her daughter’s case who was jabbed with the vaccine, he said she developed mild temperature after the first dose, and the same thing followed after she was given the second injection. “(…) and then everything cleared up, she feels good and the [antibody] titers are high”, Putin stated.
Russian health minister Mikhail Murashko said the vaccine will be produced by the company Binnopharm and the Gamaleya Research Institute. Murashko also revealed many countries are starting to show interest in the vaccine.
(This is a developing story. More details awaited)